We and others have previously shown that pathological FUS affects the proper biosynthesis and nucleocytoplasmic trafficking of snRNPs, the key constituent of the spliceosome, and these mechanism might explain the alterations in the splicing of several target genes identified in cellular and animal models of FUS-ALS [22–24]. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.